Misobit 50 Tablet
Marketer
Lupin Ltd
Salt Composition
Miglitol (50mg)
Overview Misobit 50 Tablet
Glycemia 50mg tablets are indicated for managing type 2 diabetes. This medication aids in postprandial blood glucose regulation, employed when dietary modifications and other comparable treatments prove insufficient. Administer Glycemia 50mg immediately prior to, or with the initial bite of, a meal. Dosage frequency is determined by your physician to optimize glycemic control, potentially increasing incrementally. Discontinuation requires medical consultation; abrupt cessation may elevate blood sugar, risking severe complications such as renal impairment and vision loss. Glycemia 50mg forms part of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Common adverse reactions include skin eruptions, flatulence, abdominal discomfort, and diarrhea; consult your physician if these persist or are troublesome. While Glycemia 50mg alone does not induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Glucose should be used to treat hypoglycemic episodes; sucrose or other common sugars may be ineffective. Prior to commencing therapy, inform your physician of any hepatic or renal dysfunction. This medication is contraindicated in individuals with bowel inflammation or ulceration (e.g., Crohn's disease, ulcerative colitis). Pregnant or lactating women should seek medical guidance before initiating treatment. Complete disclosure of all medications is vital for safety. Limit alcohol consumption while using Glycemia 50mg to mitigate hypoglycemia risk.
Uses of Misobit 50 Tablet
Managing type 2 diabetes
Major Benefits of Misobit 50 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Misobit 50 Tablets should be taken with meals.
Common Side effects of Misobit 50 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Misobit 50 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Misobit 50 Tablets should be administered with food.
How Misobit 50 Tablet works:
Misobit 50 Tablet is an antidiabetic medication that works by blocking the activity of intestinal enzymes which digest complex carbohydrates. This action reduces postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Misobit 50 Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Misobit 50 Tablet during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and Misobit 50 Tablet use appear compatible. Available data from human studies indicate minimal infant risk associated with the medication.
DrivingSAFE
Driving ability is typically unaffected by Misobit 50 Tablet.
KidneyCAUTION
Patients with kidney impairment should use Misobit 50 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. Misobit 50 Tablet is contraindicated in individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
Misobit 50 Tablet appears to be well-tolerated by individuals with hepatic impairment. Current evidence indicates dose modification may not be necessary for this population. Physician consultation is recommended.
What if you forget to take Misobit 50 Tablet :
Omit any missed Misobit 50 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Misobit 50 Tablet
| Label | Value |
|---|---|
| Chemical Category | Nojirimycin Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |






